There have been few epidemiological studies on the gene-environmental interaction between the aldosterone synthase gene (CYP11B2) T-344C polymorphism and sodium in relation to blood pressure in a freeliving general population. We hypothesized a priori that persons with the T allele of CYP11B2 would have elevated blood pressure levels in response to a higher sodium intake, and thus the association between the T-344C polymorphism and blood pressure would be more evident among persons with a high sodium intake than among those with a low sodium intake. Study subjects were 2,823 men and women aged 30-74 in a Japanese community. We examined the associations between the T-344C polymorphism and blood pressure levels, stratified by sodium variables estimated by 24-h urinary sodium excretion and a dietary questionnaire. There was no significant difference in blood pressure levels among the CC, TC and TT groups for either or both sexes. However, among persons with higher sodium excretion, mean systolic blood pressure levels tended to be higher in those with the TC ( + 3.0 mmHg, p =0.06) and TT ( + 2.9 mmHg, p =0.07) genotypes than in those with the CC genotype, but this tendency was not seen among those with lower sodium excretion ( -4.0 mmHg, p =0.03 for TC vs. CC; -3.0 mmHg, p=0.11 for TT vs. CC; p for interaction =0.006). In conclusion, we found no association between CYP11B2 and blood pressure for total subjects or for persons with a higher sodium intake. However, a possible gene-blood pressure association among persons with higher sodium intake needs to be explored further. (Hypertens Res 2007; 30: 497-502) 
Introduction
Aldosterone is synthesized by CYP11B2, a mitochondrial cytochrome P450 enzyme. Recent biological studies suggest that increase in aldosterone and thereby in epithelial Na + channel (ENaC) activity may play an important role in the etiology of hypertension (1) . T−344C polymorphism (thymidine-to-cytosine substitution at position −344 in the regulatory region) of the CYP11B2 gene was extensively examined as a candidate gene of hypertension because high levels of aldosterone increase subsequent risk of hypertension (2) . Some studies (3) (4) (5) (6) , but not all (7) (8) (9) (10) (11) (12) , reported that the T allele was associated with blood pressure/hypertension, especially for low-renin hypertension (4, 5, 13) , which is considered to correspond to salt-sensitive hypertension (14) . However, no community-based study has been conducted to examine the genetic association between CYP11B2 and saltsensitive hypertension, probably due to the difficulty in identifying this type of hypertension in community-based samples.
Therefore, we conducted a large community-based observational study of 2,823 Japanese men and women to examine associations of CYP11B2 polymorphism with blood pressure levels, stratified by sodium variables. Our a priori hypothesis was that persons with the T allele of CYP11B2 would have elevated blood pressure in response to high sodium intake, and thus the association between T−344C polymorphism and blood pressure levels would be more evident among persons with high sodium intake.
Methods

Study Population
Subjects were free-living residents of a farming community of Kyowa (census population in 2000: n= 17,145), which was similar to that examined in our previous studies (15) (16) (17) . Briefly, we recruited subjects aged 30-74 years who had participated in the 2001 cardiovascular risk survey (n= 2,972). Physicians explained the protocol to all participants, and obtained written informed consent from 95% (n= 2,823) of them. The data of these 2,823 persons were used in the present study. The study protocol was approved by the Medical Ethics Committee of the University of Tsukuba.
Population Surveys
The population surveys have been performed annually since 1981. Details of the surveys have been described elsewhere (15) (16) (17) . Well-trained blood pressure observers measured arterial systolic blood pressure (SBP) and fifth-phase diastolic blood pressure (DBP) using standard mercury sphygmomanometers (with a cuff 14 cm wide and 51 cm long) on the right arm of quietly seated participants after a period of at least 5-min rest. When the SBP was ≥ 140 mmHg and/or the DBP was ≥ 90 mmHg, the measurement was repeated and the average of the two readings was used in the analyses; otherwise the single reading was used. The methods of blood pressure measurement were standardized uniformly across the surveys, and blood pressure measurement training for blood pressure observers was provided before each annual survey. Hypertension was defined as an SBP of ≥ 140 mmHg and/or DBP of ≥ 90 mmHg, and/or use of antihypertensive medication. Some participants collected all urine over 24 h between the 1982 and 2005 surveys (15) . Subjects who provided urine samples of < 500 mL and/or for < 20 h, or those with incomplete collections based on records were excluded from the analyses. Consequently, 1,920 subjects completed the 24-h urine collection. In addition, all participants were asked to complete a self-administered dietary questionnaire to estimate present and past sodium intake at the 2001 survey, and 99% of the subjects successfully completed the questionnaire; the method was described in detail and validated elsewhere (17) . We used age, body mass index and alcohol intake as confounding variables, and sodium excretion, sodium intake as effect modifiers.
DNA Genotyping
CYP11B2 T−344C genotypes were determined by the allelespecific primer-polymerase chain reaction (PCR) method using Taq DNA polymerase (rTaq; Toyobo, Osaka, Japan), as described elsewhere (18, 19) . The designed allele-specific sense primers were TxR-GTCTATTAAAAGAATCCAAGG XTC for the T allele and FITC-TATTAAAAGAATCCA AGGXCC for the C allele labeled at the 5′ end either with fluorescein isothiocyanate (FITC) or with Texas red (TxR), and a 5′ biotin-end-labeled antisense primer (biotin-GGACTT TATCTTATCGTGAGATGA), in which X represents an artificial mismatch base (18) .
Statistical Analyses
The analysis of covariance and χ 2 test were used to compare sex-specific age-adjusted mean values and proportions of risk characteristics, by Tukey's multiple comparison method. The χ 2 test was used to examine whether the genotype distributions differed from those expected from Hardy-Weinberg equilibrium. The relation between genotype and blood pressure levels was adjusted by age, sex, antihypertensive medication use (yes or no), body mass index and alcohol consumption, and examined by the analysis of covariance, using Dunnett's multiple comparison method with the CC group as a reference. Further analysis was performed stratified by the medians of urinary sodium excretion and sodium intake scores to examine whether the associations between genotype and blood pressure levels were modified by sodium intake. We used dummy variables for adjustment of sex and antihypertensive medication use, and continuous variables for other covariates. The interactions between genotype and sex, stratified sodium variables, i.e., polymorphism (TT, TC, CC) × sex (men or women) or polymorphism × sodium intake/ excretion (below or beyond the median values) were tested by analysis of covariance. All statistical analyses were performed using SAS version 8.02 software (SAS Institute Inc., Cary, USA). All probability values for statistical tests were two-tailed; values of p< 0.05 were regarded as statistically significant, and values of 0.05≤ p< 0.10 as borderline significant. Blood pressure was † adjusted for age, antihypertensive medication use, body mass index, alcohol consumption, and ‡ further adjusted for survey year of 24-h urine collection. Median values are 171.2 mmol/day for urinary sodium excretion in women and 195.7 mmol/day in men, 5 for present sodium intake score in women and 6 in men, and 6 for past sodium intake score in women and 7 in men. p-values represents differences between TT and CC genotypes examined by Dunnett's multiple comparison methods.
Results
The sex-specific frequencies of CYP11B2 genotypes were 11.3%, 44.4%, and 44.4% for men, and 11.9%, 43.3%, and 44.8% for women, respectively. The genotype distribution was in Hardy-Weinberg equilibrium for men (p = 1.00) and women (p = 0.70). The mean age of the subjects was 59 years for men and 57 years for women. The prevalence of hypertension was 48% for men and 38% for women, and the respective mean values of 24-h urine sodium excretions were 205 mmol and 179 mmol (data not shown in the tables). For each sex, mean age did not vary among the CC, TC and TT genotypes (Table 1) . Neither mean SBP nor mean DBP was significantly different among the three genotypes. However, the use of antihypertensive medication was more preva-lent among women with the TT genotype than those with the CC genotype. Urinary sodium excretion was lower among men with the TC and TT genotypes than those with the CC genotype. The other variables were similar among the genotypes.
The mean values of blood pressure levels adjusted for age, antihypertensive medication use, body mass index and alcohol consumption are shown for each CYP11B2 genotype ( Table 2) . Overall, there was no significant difference in blood pressure levels. Also, we found no association between T−344C polymorphism and blood pressure levels when stratified by urinary sodium excretion, present sodium intake, and past sodium intake score (Table 2 ). However, when men and women were combined (Fig. 1) , the SBP levels among persons with the higher urinary sodium excretion tended to be positively associated with the T allele: 129.0 mmHg for the the CC genotype), and 131.9 mmHg for the TT genotype (p = 0.07), but not among those with lower sodium excretion: 137.1 mmHg for the CC genotype, 133.1 mmHg for the TC genotype (p= 0.03) and 134.1 mmHg for the TT genotype (p = 0.11). The interaction between urinary sodium excretion and genotype in relation to SBP was statistically significant (p= 0.006). The associations between CYP11B2 genotypes and blood pressure levels were not altered materially when subjects were restricted to those without antihypertensive medication (n= 1,112). For example, the SBP levels in persons with higher sodium excretion were 126.0 mmHg, 129.3 mmHg (p= 0.07) and 129.2 mmHg (p= 0.08), respectively, and those in persons with lower sodium excretion were 134.5 mmHg, 130.3 mmHg (p= 0.05) and 131.1 mmHg (p= 0.13), respectively.
Discussion
We found no significant difference in blood pressure levels between the CC, TC and TT genotypes for either sex in the total subjects. The lack of association is not surprising, because this finding was consistent with the results of previous studies (7) (8) (9) (10) (11) (12) . However, a positive association was suggested between the CYP11B2 TT genotype and SBP levels among persons with higher sodium excretion, but not for those with lower sodium excretion.
The results from previous studies examining the association between the T−344C polymorphism and blood pressure/ hypertension have been inconsistent. A Japanese populationbased study (10) showed no association between the T−344C polymorphism and 24-h ambulatory SBP or DBP, but subjects with the CC genotype showed a greater reduction in nocturnal SBP levels than those with the TC or TT genotypes. However, several population-based studies from Japanese (9), Indian (11) , and black and white English (7) showed no association between the T−344C polymorphism and blood pressure/hypertension, whereas other population-based studies from Italian (5, 12) and multi-ethnic populations (6) showed a positive association with SBP or both SBP and DBP.
Our a priori hypothesis was based on the previous reports that showed a positive association between the T−344C polymorphism and low-renin hypertension (4, 5) , which is considered to correspond to salt-sensitive hypertension (13) . Since Japanese populations have a higher sodium intake than Western countries (20) , we assumed that the high sodium intake may have helped to make the CYP11B2 gene-blood pressure association more evident. The present study supported our hypothesis. Previous studies (21) (22) (23) , however, showed no association between the T−344C polymorphism and salt sensitivity among relatively young subjects (mean age of 25 to 47 years).
Although our a priori hypothesis was not clearly supported, the present study has several strengths. The present study was the first community-based observational study of a genesodium intake interaction on blood pressure with a large sample size, which allowed us to conduct stratified analyses. Second, mean sodium intake was higher in the present Japanese subjects than in Western countries, which may have constituted an advantage for examining the gene-sodium intake interaction.
The present study has several limitations. First, we used only a single blood pressure measurement in the analyses, and thus measurement variability may have weakened the genetic associations. However, since the number of the study subjects was large, we attained enough statistical power to detect gene-blood pressure associations. Second, approximately 20% of subjects used antihypertensive medication, which may have obscured the genetic effect of blood pressure levels. However, this possibility is unlikely, since the exclusion of persons on antihypertensive medication did not alter the genetic associations materially. Last, the variation of sodium excretion by one 24-h urine sample may be large, and misclassification between the low and high sodium excretion groups is inevitable. However, since the study had a large sample size, the impact of misclassification across the stratification was probably small. In the present study, 66% of persons remained in the same group of higher or lower sodium intake after 1-5 years re-collection of urinary sodium excretion for the sub-sample.
In conclusion, the CYP11B2 T allele was not associated with high blood pressure levels for total subjects or for persons with a higher sodium intake. However, a possible geneblood pressure association among persons with a higher sodium intake needs to be explored in a future study.
